European Medicines Agency must take account of cardiovascular harm associated with degludec insulin
Research output: Contribution to journal › Journal article › Research › peer-review
| Original language | English |
|---|---|
| Journal | B M J |
| Volume | 346 |
| Pages (from-to) | f3731 |
| ISSN | 0959-8146 |
| DOIs | |
| Publication status | Published - 2013 |
- Cardiovascular Diseases, Diabetes Mellitus, Type 2, Drug Approval, Europe, European Union, Female, Government Agencies, Humans, Hypoglycemic Agents, Insulin, Long-Acting, Male, Product Surveillance, Postmarketing, Public Health, United States, United States Food and Drug Administration
Research areas
ID: 120844785